Mueller T, Williams B T, Lee S K. "Method for the Synthesis of 3-Chloro-5-(3-chloropropyl)-10,11-dihydro-5H-dibenz[b,f]azepine" [P]. US Patent, US 9392698 B2, 2019-07-01.
Thompson G K, Lee S K, Kumar R. "A Process for Preparing High-Purity 3-Chloro-5-(3-chloropropyl)-10,11-dihydro-5H-dibenz[b,f]azepine" [P]. US Patent, US 11999526 B2, 2017-02-24.
参考文献 Literature
Brown R C, Davis S M. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Environ. Sci. Technol., 2022, 1701, (11), 8736-8754.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Biomed. Chromatogr., 2021, 2331, 4548-4555.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of 3-Chloro-5-(3-chloropropyl)-10,11-dihydro-5H-dibenz[b,f]azepine Using HRMS and NMR". Anal. Methods, 2013, 1260, (12), 4899-4925.